towards multi-$billion hiv market

"Initially ATC will be developed for HIV patients who have developed resistance to multi-drug therapy. ATC has shown great potential as a therapy in the fight against multi-drug resistant HIV."

Actually AVX already indicates no any problems with the FDA approval, Just a matter of time.

The meeting results clearly means "yes" tick from FDA.

This could further open the huge Chinese HIV medicine market, which is towards multi-$Billion.

Just the begining, with $20m cash on hand, I reckon AVX's MC could exceed $350 million once the final approval on hand, that's 6 baggers from here.